MedPath
TGA Approval

HYRIMOZ adalimumab 20 mg/0.2 mL solution for injection pre-filled syringe (407662)

407662

HYRIMOZ adalimumab 20 mg/0.2 mL solution for injection pre-filled syringe

Sandoz Pty Ltd

May 15, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYRIMOZ adalimumab 20 mg/0.2 mL solution for injection pre-filled syringe (407662) - TGA 批准文号 | MedPath